Immunotherapy in multiple myeloma–possibility or probability?

Dynamic control of lymphocyte trafficking by fever-range thermal stress

Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cells

Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro

Adjuvant IL-15 does not enhance the efficacy of tumor cell lysate-pulsed dendritic cell vaccines for active immunotherapy of T cell lymphoma

Dendritic cells and vascular endothelial growth factor in colorectal cancer: correlations with clinicobiological findings

Human papillomavirus L1L2-E7 virus-like particles partially mature human dendritic cells and elicit E7-specific T-helper responses from patients with cervical intraepithelial neoplasia or cervical cancer in vitro

Active immunotherapy for advanced intracranial murine tumors by using dendritic cell-tumor cell fusion vaccines

Chemosensitization of pancreatic carcinoma cells to enhance T cell-mediated cytotoxicity induced by tumor lysate-pulsed dendritic cells

Immunoselection of functional CMRF-56+ blood dendritic cells from multiple myeloma patients for immunotherapy